Mycovia Pharmaceuticals reports first participant enrolled in Phase 2 cryptococcal meningitis study

bioMérieux launches rapid PCR test for equine respiratory diseases

Ondine Biomedical joins CAN Health Network to advance Steriwave adoption in Canada

Seegene presrnts CURECA conceptual video at ESCMID Global 2025

GC Biopharma's BARYTHRAX receives Korean regulatory approval

Seegene Inc developing fully automated PCR solution

Oxford Nanopore and Cepheid form partnership to advance sequencing-based solutions for infectious diseases

bioMérieux receives CE-marking for LUMED APSS to support antimicrobial stewardship in Europe

Ondine Biomedical's Steriwave technology reduces surgical site infections by 71% in NHS deployment

AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100

Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA

Ireland selects Conduent to enhance infectious disease management

Pharming Group reports first patient dosed in Phase II trial of leniolisib for CVID with immune dysregulation

bioMérieux receives FDA clearance for VITEK COMPACT PRO to combat antimicrobial resistance

ANI Pharmaceuticals secures FDA approval for ILUVIEN label expansion